Banner Health Report Shows Arizona Research Driving National Medical Innovation

Why It Matters

The accelerated pipeline shortens time‑to‑market for life‑saving treatments, boosting patient outcomes and reinforcing Arizona’s economy as a biotech magnet.

Key Takeaways

• $80.5M research budget fuels 1,300 active clinical studies.
• First FDA‑approved device for severe mitral annular calcification released.
• Enrolled 89,000+ participants in NIH All of Us program, 70% pediatric.
• $74.5M NIH Alzheimer prevention trial launched in Colombia.
• Supports 371 high‑skill jobs, attracting tens of millions in federal funds.

Pulse Analysis

Banner Health has emerged as one of the nation’s most prolific nonprofit research engines, allocating $80.5 million to a portfolio that now spans 1,300 clinical and translational studies across neuroscience, cardiology, oncology and orthopedics. By leveraging its integrated network of 33 hospitals and a 371‑member research team, the system translates discoveries from the laboratory to the bedside faster than many academic centers. The partnership with the University of Arizona serves as the academic backbone, while collaborations with MD Anderson, Mayo Clinic and Johns Hopkins extend the reach of its trials to a global audience.

The 2025 milestones illustrate how scale translates into tangible therapies. Banner secured the first FDA‑approved device for severe mitral annular calcification, a condition that affects roughly 30 % of seniors and previously required invasive surgery. Its enrollment of over 89,000 participants in the NIH All of Us program—accounting for nearly 70 % of the nation’s pediatric cohort—demonstrates unmatched recruitment capacity. Landmark NIH‑funded studies, including a $74.5 million Alzheimer prevention trial in Colombia and a $21.6 million investigation of hypertension‑related brain disease, position the health system at the forefront of preventive medicine.

Beyond clinical impact, Banner’s research enterprise fuels Arizona’s economy and talent pipeline. The operation sustains 371 high‑skill jobs and draws tens of millions of federal dollars annually, reinforcing the state’s reputation as a biotech hub. Training more than 1,300 residents and fellows each year creates a pipeline of clinicians versed in cutting‑edge research, while the dissemination of biomarker tests and tissue samples to ten countries amplifies the system’s global footprint. As the organization reinvests every dollar into care and discovery, its model offers a blueprint for other health systems seeking to blend community benefit with rapid innovation.